ArticleBMJ open2023

Long-course chemoradiation plus concurrent/sequential PD-1 blockade as neoadjuvant treatment for MMR-status-unscreened locally advanced rectal cancer: protocol of a multicentre, phase 2, randomised controlled trial (the POLAR-STAR trial).

Kai Pang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.